Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
Kimberly-Clark Corporation will acquire Kenvue Inc. in a nearly $50 billion merger, creating one of the world's largest consumer health companies.Kenvue and Kimberly-Clark announced the $48.7 billion ...